Stock listing
Bionano Genomics, Inc.
- Ticker
- BIVA:BNGO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BIVA
- Currency
- MXN
About Bionano Genomics, Inc.
Bionano Genomics, Inc. (ticker: BNGO) is a public company based in the United States, specializing in genomic analysis technology. Bionano focuses on providing innovative solutions for genome mapping and analysis, aiming to enhance research and clinical applications in genomics.
Latest news from Bionano Genomics, Inc.
Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
Sep 23, 2026
Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
Sep 14, 2026
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
Sep 10, 2026
Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
Sep 8, 2026